| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| May 7, 2026 | ±4.0% | -0.7% | over-priced |
| February 4, 2026 | ±2.5% | +8.1% | under-priced |
| November 6, 2025 | ±2.6% | +1.9% | over-priced |
| May 1, 2025 | ±3.1% | -1.3% | over-priced |
| February 5, 2025 | ±2.4% | +1.7% | over-priced |
| May 1, 2024 | ±1.8% | +9.6% | under-priced |
| February 7, 2024 | ±2.2% | +2.2% | — |
| November 1, 2023 | ±1.8% | -2.0% | under-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q3 FY2026 | $0.60 | $5.9B | $278M |
| Q2 FY2026 | $0.38 | $5.4B | $177M |
| Q1 FY2026 | $0.11 | $5.7B | $262M |
| Q4 FY2025 | $-0.06 | $5.1B | $-39M |
Amcor plc Ordinary Shares (AMCR) reports in 77 days, with the next report estimated for August 29, 2026. Across the last 8 reports, options priced an average ±2.5% earnings move while the stock actually moved 3.4% on average — the market has been roughly fair on AMCR's earnings risk. Fundamentals into the print: EPS up 341.2% year-over-year, revenue up 77.4%. QuantLogix's live 5-factor engine currently reads AMCR as a neutral at 48/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →